Hepatocellular carcinoma: Latest developments

Natasha Walzer, Laura M. Kulik

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations


PURPOSE OF REVIEW: This review primarily focuses on new developments in the field of hepatocellular carcinoma. RECENT FINDINGS: Potential preventive strategies in the development of hepatocellular carcinoma are being recognized. Novel molecular markers identified may aid in the diagnosis of early hepatocellular carcinoma in patients with chronic hepatitis C virus. Prognostic information gained by preoperative tumor biopsy is being investigated. Treatment of early hepatocellular carcinoma with resection versus primary or salvage transplantation continues to be debated. Expansion of selection criteria beyond the Milan criteria appears feasible. The role of living donor liver transplantation in hepatocellular carcinoma will require further study to determine the risk of recurrence. Improvements in chemoembolization with drug eluting beads appear promising. SUMMARY: Further insight into the pathogenesis of hepatocellular carcinoma will result in the continued evolution of our approach and management of the disease. Tailored therapies based on tumor biology are needed to improve treatment response and ultimately patient survival.

Original languageEnglish (US)
Pages (from-to)312-319
Number of pages8
JournalCurrent Opinion in Gastroenterology
Issue number3
StatePublished - May 2008


  • Hepatocellular carcinoma
  • Living donor liver transplant
  • Resection
  • Therapy

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Hepatocellular carcinoma: Latest developments'. Together they form a unique fingerprint.

Cite this